The Family Firm’s Eastman Chemical EMN Stock Holding History

The Family Firm’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-140	Closed	-$13.7K	–	390
2024 Q2	$13.7K	Buy	+140	New	+$13.9K	﹤0.01%	630

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

The Family Firm's EMN Position: Q3 2024 in Review

The Family Firm sold out of Eastman Chemical (EMN) in Q3 2024, closing a stake of 140 shares — an estimated $13.7K sold.

The Family Firm first reported a position in EMN in Q2 2024 and held it in 1 quarter. The position peaked at $13.7K in Q2 2024. 783 funds tracked by Wall St. Rank hold EMN as of Q3 2024.

The Family Firm reported no remaining Eastman Chemical position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 140 Eastman Chemical shares in Q3 2024, an estimated $13.7K.
The Family Firm first reported a position in Eastman Chemical in Q2 2024 and held it in 1 quarter.
The Family Firm's Eastman Chemical position peaked at $13.7K in Q2 2024.
783 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.